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Purpose: Poor sleep quality is a common problem among middle-aged women. Few studies, 
however, have assessed differences in sleep quality among premenopausal, perimenopausal, 
and postmenopausal women and related risk factors in Korea women. The aim of this study 
was to assess sleep quality and factors associated therewith according to menopausal status 
in Korean women.
Patients and Methods: This study was based on the 2016 Korean Study of Women’s 
Health Related Issues (K-Stori), a cross-sectional survey employing nationally representative 
random sampling. In total, 3000 Korean women aged 45 to 64 years completed the 
Pittsburgh Sleep Quality Index (PSQI). Comparison of demographic characteristics and 
sleep quality among pre-, peri-, and postmenopausal women was conducted.
Results: Among the participants, 26% suffered from poor sleep quality based on the PSQI. 
The prevalence of poor sleep quality increased with later menopausal stage (from 18.8% in 
the premenopausal stage to 29.5% in the postmenopausal stage P <0.001). Multivariate 
logistic regression analysis showed that peri- and postmenopausal women were 1.50 and 
1.73 times more likely to have poor sleep quality in comparison to premenopausal women, 
respectively. Chronic disease, depression, at-risk drinking, taking dietary supplements, and 
single women were associated with a higher likelihood of having poor sleep quality. Health 
status, at-risk drinking, chronic illness, dietary supplementation, and depression were sig-
nificantly associated with poor sleep quality.
Conclusion: Poor sleep quality appears to be prevalent in peri- and postmenopausal women 
in Korea. The management of sleep quality during menopause transition is important, and 
further research on how sleep disturbances influence the health status of women in meno-
pausal transition is required.
Keywords: menopause, sleep quality, Pittsburgh sleep quality index
Introduction
Menopausal transition refers to the period when the female body produces less 
estrogen, signaling the end of egg production. Once women start this transition 
naturally, it cannot be stopped. During this time, women commonly report 
experiencing reduced sleep quality, including trouble falling asleep and frequent 
nocturnal awakenings,1–6 and numerous factors are assumed to be contributors to 
sleep disturbances in mid-life women, including age, social factors, perceived 
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stress, depression, physical activity, alcohol intake, body 
weight, and history of chronic diseases.1,7–10 Midlife 
women transitioning menopause and postmenopause are 
more likely to report sleep difficulties, with prevalence 
rates of self-report sleep difficulties ranging between 
40% and 56%, compared to premenopausal women in 
the late reproductive stage, who have rates of 31%.1,4 
Further, a systematic review and meta-analysis showed 
that poor sleep quality and inappropriate sleep duration 
pose increased risks of cardiovascular diseases, all-cause 
mortality, and cancer-related mortality11 and that sleep 
disturbances are associated with psychological symp-
toms, such as anxiety and depression, both of which 
are more prevalent in women during menopause.5,12–14
While several studies have indicated that menopausal 
status without vasomotor symptoms is independently asso-
ciated with an increased risk of poor sleep quality,5,15 
others have suggested that it is not and is multi- 
factorial.13,16,17 Moreover, previous studies have indicated 
that there are racial differences in sleep in midlife women, 
suggesting that the prevalence of poor sleep quality is 
lower in Asian populations in comparison to other racial 
groups.4,18,19 However, most sleep-related studies have 
been conducted on Caucasian populations,4 and such evi-
dence is largely unavailable for Korea. Although one pre-
vious study examined the prevalence of poor sleep quality 
and its associated factors in middle-aged Korean women, 
this study was conducted at a single center, and their 
results cannot be generalized to all menopausal women 
in Korea.20
Therefore, this population-based study was conducted 
to assess associations between sleep quality and menopau-
sal status and to investigate factors related with sleep 
quality among mid-life women in Korea.
Materials and Methods
Study Population
The study was based on the 2016 Korean Study of 
Women’s Health Related Issues (K-Stori), a cross- 
sectional survey that utilized nationally representative ran-
dom sampling to explore life-cycle specific women’s 
health issues in Korea. A detailed description of K-Stori 
has been provided elsewhere.21 In brief, we randomly 
sampled 3000 women in each stage of the female life 
cycle (Adolescence, 14–17 years; Childbearing, 19–44 
years; Pregnancy and Postpartum, 19–44 years; 
Menopause, 45–64 years; and Older Adulthood, 65–74 
years) by multistage random sampling according to the 
sizes of population per region and geographic area, based 
on 2010 Population and Housing Census. Trained inter-
viewers from a professional research agency conducted 
door-to-door surveys to assess study eligibility. Among 
37,334 eligible women, 15,084 women completed in- 
person interview surveys (adolescents completed online 
surveys) between April 2016 and June 2016. The response 
rate of K-Stori was 40.4%. Of the 15,084 women who 
participated in the K-Stori, 84 women who did not answer 
the main questions or were over-sampled were excluded 
from the analysis.22 For final analysis, we excluded 12,000 
women in adolescence, childbearing, pregnancy and post-
partum, and older adulthood stages. Thus, a total of 3000 
Korean women in menopause stages aged 45 to 64 years 
were included in the final analysis.
This study was approved by the Institutional Review 
Board (IRB) of the National Cancer Center, Korea 
(approval number: NCC2016-0062). An approved study 
description was provided to all eligible participants. The 
study description covered the research purpose, subject, 
content, duration, voluntary participation, withdrawal of 
consent, expected risks and benefits from participating in 
the research, publication of the study results, and confi-
dentiality. If the subjects agreed to participate in the study 
after reading the study description, participants were asked 
to provide written informed consent. This study was con-
ducted in accordance with the Declaration of Helsinki.
Measurements
The surveys collected information on sociodemographic 
factors, self-health status, health awareness, psychological 
health, stress levels, health concerns, menstrual and repro-
ductive health, health behaviors, medical service use, 
health information, social support, gender role and socio-
economic status. Blood pressure and body weight and 
height were measured, and BMI was calculated as body 
weight divided by body height squared.
The menopausal transition refers to the years leading 
up to menopause, or final menstrual period, when endo-
crinological, biological, and clinical features of approach-
ing menopause commence.22 In the current study, 
menopausal status was determined by menstrual history: 
premenopausal (women having regular menses), perime-
nopausal (irregularities >7 days from normal cycle),23 and 
postmenopausal (no menses in the last 12 months).
Sleep quality was determined using the Pittsburgh 
Sleep Quality Index (PSQI),24 a self-reported 
https://doi.org/10.2147/NSS.S298397                                                                                                                                                                                                                                  
DovePress                                                                                                                                                        
Nature and Science of Sleep 2021:13 1138
Hwang et al                                                                                                                                                           Dovepress
Powered by TCPDF (www.tcpdf.org)
questionnaire detailing sleep quality over the period of 1 
month. A validated Korean version of the PSQI was 
used.24 In total, 19 items were measured to generate 
seven component scores, which are subjective sleep qual-
ity, sleep latency, sleep duration, habitual sleep efficiency, 
sleep disturbance, use of sleeping medication, and daytime 
dysfunction. The scores of the seven components scores 
were summed together to yield a global PSQI score (total 
score of 21), with higher scores indicating poorer sleep 
quality. A global PSQI score >5 was defined as poor 
overall sleep quality.
The Tolerance-Annoyed, Cut down, Eye-opener 
(T-ACE) screening tool was used to identify at-risk drink-
ing, with a T-ACE score of 2 or higher defined as being at 
potential risk.25 Korean Versions of the Perceived Stress 
Scale (PSS) were utilized to measure stress: the original 
PSS contains 14 items, but a 4-item version is also avail-
able for quick measurement, which was used in this study. 
The Korean version of the PSS was validated.26 The 
Patient Health Question-9 (PHQ-9), a diagnostic instru-
ment for common mental disorders, particularly depres-
sion, was used in this study to determine the severity of 
depression.27
Statistical Analysis
All statistical analyses were performed using STATA 12.0 
software (Stata Corp. L. P., College Station, Texas). 
Demographic and sleep quality variables among groups 
pre-, peri-, and postmenopausal women were compared. 
Categorical variables are presented as percentages and 
were compared using the chi-square test and Fisher’s 
exact test. Continuous variables are expressed as means 
(standard deviations). T-tests and analysis of variance was 
conducted, followed by Tukey’s post-hoc analysis, to iden-
tify significant differences among the women according to 
menopausal status. Variance inflation factor (VIF) was 
assessed prior to the logistic analyses to assess collinearity 
between independent variables, because multicollinearity 
may increase the variance of the regression coefficients 
and make them unstable We found the VIFs were all less 
than 10, thus indicating no collinearity. Univariate logistic 
regression analysis was conducted to examine associations 
between poor sleep quality and different variables. Then, 
variables with a P value <0.05 from univariate analysis 
were selected for multivariable analysis. In the multivari-
able analysis, we applied age-adjusted weighting values 
for Korean women from the 2010 Population and Housing 
Census. In the analysis, a global PSQI score was 
categorized as a binary outcome: Women with a PSQI 
score ≤5 were categorized as having good quality sleep, 
while those with a PSQI score >5 were categorized as 
having poor quality sleep. We estimated the odds of hav-
ing poor sleep quality according to menopausal status. 
P values <0.05 were considered statistically significant.
Results
The general demographic, health, psychological health, 
and lifestyle variables are presented in Table 1. Of the 
3000 participants, 770 (25.67%) were premenopausal, 
398 (13.27%) were perimenopausal and 1832 (61.07%) 
were postmenopausal. All variables were significantly dif-
ferent among the three menopausal status groups 
(P <0.05).
Table 2 shows score for sub-scales of PSQI according 
to menopausal status. There were significant differences in 
all sub-scales of PSQI (subjective sleep quality, sleep 
latency, sleep duration, habitual sleep efficiency, sleep 
disturbance, use of sleep medication and daytime dysfunc-
tion) according to menopausal stage (All P <0.05).
Table 3 comprises PSQI scores according to menopau-
sal status. Among the participants, 26% suffered from poor 
sleep quality based on the PSQI. Post-hoc analysis 
revealed that mean PSQI scores were significantly higher 
in peri- and postmenopausal women than in premenopau-
sal women (P <0.05). Both total scores and scores of each 
item showed an increasing trend from premenopausal to 
postmenopausal status, except for sleep duration. In com-
parison to premenopausal women, postmenopausal women 
were significantly more likely to report poorer subjective 
sleep quality (P <0.001), prolonged sleep latency (P= 
0.005), lower habitual sleep efficiency (P= 0.038), fre-
quent use of sleep medication (P <0.0001), and daytime 
dysfunction (P <0.001). The prevalence of poor sleep 
quality increased with later menopausal stage (from 
18.8% in the premenopausal stage to 29.5% in the post-
menopausal stage P <0.001)
Table 4 presents the mean PSQI scores by sociodemo-
graphic characteristics and the results from logistic regres-
sion analysis to identify factors associated with poor quality 
of sleep. There were statistically significant differences in 
mean sleep quality scores according to menopausal stages, 
age, income level, marital status, dietary supplement con-
sumption, chronic illness, risk drinking, depression, and 
stress level (All P <0.05). Univariable logistic regression 
analysis indicated that menopause stage, age, income level, 
marital status, consumption of dietary supplements, chronic 
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illness status, risk drinking, and depression were associated 
with poor sleep quality (P <0.05). Multivariable logistic 
regression analysis showed that perimenopause (Odds ratio 
[OR], 1.50; 95% Confidence Interval [CI] 1.07 to 2.11) and 
postmenopause states (OR, 1.73; 95% CI 1.26 to 2.39), 
single women (OR, 1.51; 95% CI 1.11 to 2.06), taking 
dietary supplements (OR, 1.72; 95% CI 1.39 to 2.13), 
chronic health illness (OR, 1.50; 95% CI 1.20 to 1.87), at- 
Table 1 Demographic Characteristics According to Menopausal Status
Total Menopause Stage, n (%) P value
Pre Peri Post
Total 3000 (100) 770 (25.67) 398 (13.27) 1832 (61.07)
Age, mean (S.D) 54.43 (5.65) 49.37 (3.96) 49.99 (3.44) 57.51 (4.31) <0.0001
Income level <0.0001
< $1990 313 (10.43) 36 (4.68) 18 (4.52) 259 (14.14)
$2000–$3990 1418 (47.27) 355 (46.10) 146 (36.68) 917 (50.05)
> $4000 1269 (42.30) 379 (49.22) 234 (58.79) 656 (35.81)
Marital Status <0.0001
Married 2705 (90.17) 717 (93.12) 372 (93.47) 1616 (88.21)
Single 295 (9.83) 53 (6.88) 26 (6.53) 216 (11.79)
Education level <0.0001
Middle School and lower 595 (19.83) 34 (4.42) 24 (6.03) 537 (29.31)
High School 1703 (56.77) 446 (57.92) 228 (57.29) 1029 (56.17)
University and higher 702 (23.40) 290 (37.66) 146 (36.68) 266 (14.52)
Consumption of dietary supplementsa <0.0001
No 1006 (33.53) 305 (39.61) 137 (34.42) 564 (30.79)
Yes 1994 (66.47) 465 (60.39) 261 (65.58) 1268 (69.21)
BMI <0.0001
<25 2423 (80.77) 663 (86.10) 334 (83.92) 1426 (77.84)
� 25 577 (19.23) 107 (13.90) 64 (16.08) 406 (22.16)
Consumption of coffee <0.0001
No 435 (14.50) 68 (8.83) 35 (8.79) 332 (18.12)
Yes 2565 (85.50) 702 (91.17) 363 (91.21) 1500 (81.88)
Regular exercise 0.022
No 1741 (58.03) 476 (61.82) 237 (59.55) 1028 (56.11)
Yes 1259 (41.97) 294 (38.18) 161 (40.45) 804 (43.89)
Self-reported health status <0.0001
Moderate 2671 (89.03) 732 (95.06) 368 (92.46) 1571 (85.75)
Bad 329 (10.97) 38 (4.94) 30 (7.54) 261 (14.25)
Chronic illness status <0.0001
No 2234 (74.47) 672 (87.27) 330 (82.91) 1232 (67.25)
Yes 766 (25.53) 98 (12.73) 68 (17.09) 600 (32.75)
At-risk drinking <0.0001
Low 2647 (88.23) 678 (88.05) 322 (80.90) 1647 (89.90)
High 353 (11.77) 92 (11.95) 76 (19.10) 185 (10.10)
Depression, mean (S.D) 2.43 (2.99) 2.04 (2.56) 2.44 (2.53) 2.60 (3.23) <0.0001
Stress level in everyday life, mean (S.D) 6.92 (2.01) 6.94 (2.06) 7.23 (2.00) 6.84 (1.99) 0.0015
Notes: aDietary supplements included vitamins, dietary supplements, nutritional supplements (omega-3, calcium, folic acid, beta-carotene, etc.) and functional foods 
(isoflavones, evening primrose oil, pomegranate extract, etc). 
Abbreviation: S.D, standard deviations.
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risk drinking (OR, 1.53; 95% CI 1.17 to 2.02), and depres-
sion (OR, 4.16; 95% CI 3.32–5.22) posed an increased risk 
of poor sleep quality in women.
Discussion
In this study, we aimed to assess associations between 
sleep quality and menopausal status, as well as demo-
graphic and health-related factors associated with sleep 
quality among Korean women. We discovered that about 
26% of surveyed women aged 45–64 years were having 
poor sleep quality during mid-life (global PSQI scores >5). 
One previous study conducted in the United States 
reported that that the overall prevalence of poor sleep 
quality complaints (PSQI >5) was 66%, and the preva-
lence thereof was significantly higher among African 
Americans than Caucasians.18 In Asia, one study con-
ducted in Hong Kong reported that the prevalence of 
poor sleep quality in mid-life women aged 45–55 years 
Table 2 Sub-Scales of the Pittsburgh Sleep Quality Index (PSQI) According to Menopausal Status
PSQI Items Menopause Stage P value
Pre (n=770) Peri (n=398) Post (n=1832)
Subjective sleep quality <0.0001
Very good 115 (14.9) 59 (14.8) 200 (10.9)
Good 553 (71.8) 274 (68.8) 1221 (66.7)
Bad 98 (12.7) 59 (14.8) 392 (21.4)
Very bad 4 (0.5) 6 (1.5) 19 (1.0)
Sleep latency (minutes) 0.001
≤15 309 (40.1) 152 (38.2) 687 (37.5)
16~30 364 (47.3) 180 (45.2) 814 (44.4)
31~60 86 (11.2) 60 (15.1) 254 (13.9)
> 60 11 (1.4) 6 (1.5) 77 (4.2)
Sleep duration (hours) 0.049
>7 236 (30.7) 102 (25.6) 603 (32.9)
6–7 453 (58.8) 261 (65.6) 1064 (58.1)
5–6 70 (9.1) 27 (6.8) 144 (7.9)
<5 11 (1.4) 8 (2.0) 21 (1.2)
Habitual sleep efficiency (%) 0.114
>85 717 (93.1) 367 (92.2) 1661 (90.7)
75~84 46 (6.0) 26 (6.5) 131 (7.2)
65~74 5 (0.7) 1 (0.3) 26 (1.4)
<65 2 (0.3) 4 (1.0) 14 (0.8)
Sleep disturbance <0.0001a
None during the last month 207 (26.9) 101 (25.4) 374 (20.4)
< Once a week 548 (71.2) 276 (69.4) 1309 (71.5)
1–2 times per week 15 (2.0) 21 (5.3) 147 (8.0)
≥3 times per week 0 (0.0) 0 (0.0) 2 (0.1)
Use of sleep medication 0.001
None the last month 737 (95.7) 371 (93.2) 1690 (92.3)
< Once a week 29 (3.8) 20 (5.0) 75 (4.1)
1–2 times per week 3 (0.4) 6 (1.5) 46 (2.5)
≥3 times per week 1 (0.1) 1 (0.3) 21 (1.2)
Daytime dysfunction <0.0001
None the last month 434 (56.4) 204 (51.3) 826 (45.1)
< Once a week 241 (31.3) 115 (28.9) 636 (34.7)
1–2 times per week 85 (11.0) 70 (17.6) 334 (18.2)
≥3 times per week 10 (1.3) 9 (2.3) 36 (2.0)
Notes: Differences were considered significant at P < 0.05. Unadjusted data are presented as a frequency and percent. a P-value from Fisher’s exact test.
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was about 26%, similar to the results of our study.13 One 
Korean study also found that the overall prevalence of 
poor sleep quality was 19.4%.20 Several studies have 
shown that there are strong associations between sleep 
problems and the severity of menopausal 
symptoms.8,10,28 The Study of Women’s Health Across 
the Nation, which is the largest cross-racial/multiethnic 
study of menopausal symptoms, found that in comparison 
to Caucasian women, Chinese, Japanese, African 
American, and Hispanic women reported significantly 
fewer menopausal symptoms, even after controlling for 
health and lifestyle factors.19,29 We suspect that variations 
in symptom reporting across race/ethnicity may contribute 
to the lower prevalence of poor sleep quality among Asian 
women.
In the current study, we noted that the prevalence of 
poor sleep quality increased significantly with transition 
from a premenopause to perimenopause (1.50 times) state 
and that postmenopausal women faced a 1.73 times higher 
risk of having poor sleep quality than premenopausal 
women. This was similar to results in the majority of 
previous studies.13,16,30 In a recent meta-analysis of cross- 
sectional data from 24 studies reported that women in 
perimenopause (OR, 1.60; 95% CI, 1.40–1.82), postmeno-
pause (OR, 1.67; 95% CI, 1.46–1.91), and surgical meno-
pause (OR, 2.17; 95% CI, 1.80–2.61) had higher odds of 
experiencing sleep disturbance, relative to 
premenopause.31
According to previous studies, menopausal status alone 
could account for the increased risk of poor sleep quality 
in middle-aged women, and our results are consistent 
therewith. Meanwhile, however, a few studies have 
suggested that vasomotor symptoms, as well as depressive 
symptoms, may be the primary contributors to sleep pro-
blems and that menopausal status might be insignificant 
when these factors are taken into consideration.13,16,17 
Multivariable logistic regression analysis in the present 
study indicated that the consumption of a dietary supple-
ment, at-risk drinking, chronic illness, and depression are 
independent risk factors for poor sleep quality, in addition 
to menopausal status. At-risk drinking is a known risk 
factor for poor sleep quality,16 and good sleep quality is 
required for good physical and psychological health. In 
general, depression is more common in women during 
menopausal transition, and in parallel with previous 
results, we found that depression was associated with 
a 4.16 folds increase in the risk of having poor sleep 
quality in middle-aged women, consistent with previous 
research. Interestingly, although prior studies have 
reported that increased stress leads to poor sleep 
quality,13 our analyses indicated that stress was not sig-
nificantly associated with quality of sleep. The consump-
tion of a dietary supplement, however, was significantly 
associated with poor sleep quality. We assume that women 
with poor sleep quality may have sought dietary supple-
ments in an effort to improve their overall health status or 
sleep quality.32
There are limitations to this study. Because this study 
was conducted as a cross-sectional study, our results are 
unable to definitively support causal relationships between 
menopausal status and PSQI scores. As another limitation, 
all of the results of our study were based on subjective 
assessments, such as self-reported instruments, and thus, 
objective assessments, such as polysomnography, would 
Table 3 Analysis of PSQI Scores According to Menopausal Status
PSQI Items Menopause Stage P value
Pre Peri Post
Subjective sleep quality 0.99±0.55c 1.03±0.60c 1.13±0.59a,b <0.001
Sleep latency 0.74±0.71c 0.80±0.74 0.85±0.81a 0.005
Sleep duration 0.81±0.65 0.85±0.62 0.77±0.63 0.048
Habitual sleep efficiency 0.08±0.32c 0.10±0.40 0.12±0.43a 0.038
Sleep disturbance 0.75±0.48c 0.80±0.52 c 0.88±0.52a <0.001
Use of sleep medication 0.05±0.25c 0.09±0.35 0.13±0.48a <0.001
Daytime dysfunction 0.57±0.73b,c 0.71±0.83a 0.77±0.81a <0.001
Total score (21 items) 3.99±1.92b,c 4.37±2.31a 4.64±2.53a <0.001
Good (total score of ≤5), n (%) 625 (81.2) 289 (72.6) 1292 (70.5) <0.001
Bad (total score >5), n (%) 145 (18.8) 109 (27.4) 540 (29.5) <0.001
Notes: Differences were considered significant at P < 0.05. Data are presented as means ± standard deviations. aSignificantly different from premenopause. bSignificantly 
different from perimenopause. cSignificantly different from postmenopause.
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be required for more accurate results. Previous studies 
have emphasized that the severity of vasomotor symptoms 
might be influenced by the association between menopau-
sal status and sleep problems, not just menopausal 
status.13,16,33 Vasomotor symptoms, however, could not 
be considered in our investigation due to a lack of data. 
Notwithstanding, mean PSQI global scores in postmeno-
pausal women who had visited a hospital due to vasomotor 
symptoms, such as hot flashes, sweating, and palpitation, 
were higher than those in women who had not experienced 
vasomotor symptoms. The strengths are that we utilized 
nationwide data collected via a stratified, multistage, ran-
dom sampling strategy, making the data representative of 
the general Korean population.
Conclusions
Our study findings suggest that the prevalence of poor sleep 
quality is relatively lower among midlife Korean women in 
Table 4 Results from Logistic Regression Analysis to Identify Factors Associated with Poor Sleep Quality
PSQI Score Tukey’s HSD/P value Univariate Analysis Multivariate Analysis
Mean (S.D) OR (95% CI) ORe (95% CI)
Menopause Stages b*,c***>a
Premenopausea 3.99 (1.92) 1.00 1.00
Perimenopauseb 4.38 (2.30) 1.78 (1.29–2.45) 1.50 (1.07–2.11)
Postmenopausec 4.64 (2.53) 1.83 (1.46–2.31) 1.73 (1.26–2.39)
Age c,d**>a
45–49a 4.15 (2.17) 1.00 1.00
50–54b 4.44 (2.29) 1.38 (1.06–1.80) 1.12 (0.83–1.52)
55–59c 4.56 (2.50) 1.30 (1.00–1.69) 0.76 (0.54–1.09)
59–64d 4.60 (2.49) 1.29 (0.99–1.67) 0.71 (0.49–1.03)
Income level a>b,c***
< $1990a 5.02 (3.02) 1.00 1.00
$2000–$3990b 4.44 (2.28) 0.72 (0.54–0.96) 0.91 (0.66–1.26)
> $4000c 4.29 (2.28) 0.61 (0.45–0.82) 0.81 (0.58–1.15)
Marital Status <0.001
Married 4.38 (2.33) 1.00 1.00
Single 4.91 (2.68) 1.66 (1.24–2.20) 1.51 (1.11–2.06)
Consumption of Dietary Supplement <0.001
No 4.02 (2.35) 1.00 1.00
Yes 4.65 (2.36) 1.66 (1.35–2.03) 1.72 (1.39–2.13)
Chronic illness status <0.001
No 4.18 (2.16) 1.00 1.00
Yes 5.18 (2.78) 1.97 (1.62–2.40) 1.50 (1.20–1.87)
Risk Drinking <0.001
Low 4.31 (2.24) 1.00 1.00
High 5.41 (3.05) 1.92 (1.48–2.49) 1.53 (1.17–2.02)
Depression <0.001
No Depression 4.05 (2.04) 1.00 1.00
Depression 6.31 (2.92) 4.64 (3.73–5.78) 4.16 (3.32–5.22)
Stress level in everyday life b,c*>a
Almost nonea 4.17 (2.15) 1.00 1.00
Feel slight stressb 4.49 (2.42) 1.21 (0.96–1.52) 1.09 (0.86–1.38)
Feel a lot of stressc 5.04 (2.22) 1.38 (0.68–2.80) 1.22 (0.58–2.54)
Notes: a, b, c, dComparing mean PSQI values by conducting Tukey’s HSD test. Differences were considered significant at *P<0.05, **P<0.01, ***P<0.001. eAdjusted for 
menopause stage, age, income level, marital status, consumption of dietary supplement, chronic illness status, risk drinking, depression, and stress level in everyday life. 
Abbreviations: OR, Odds ratio; CI, Confidence Interval; HSD, Honestly Significant Difference.
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comparison to other countries. Similar to previous studies, 
we found that poor sleep quality was more prevalent in peri- 
and postmenopausal women than premenopausal women. 
We also discovered that menopausal status, the consumption 
of a dietary supplement, chronic illness, at-risk drinking, and 
depression show statistically significant associations with 
poor sleep quality. Future studies on how sleep disturbances 
influence the health status of women in menopausal transi-
tion would be beneficial to the management of women in 
menopausal transition.
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